objectiveFIELD®

Frequently Asked Questions &

Specifications

Frequently Asked Questions

Thank you for your interest in the objectiveFIELD Analyzer (OFA). The acquisition of this exciting new technology is complete and we are hard at work preparing to commercialize the device. objectiveFIELD is FDA 510(k) cleared and CE MARK activities have been initiated.  We will be updating the website as information becomes available.

The interest in objectiveFIELD is extraordinarily high. We are happy to add you to the email list so that you are among the first to know about important updates and product availability. Please scroll to the bottom of this page and complete the form or call +1 (949) 576-2200.

The objectiveFIELD Analyzer (OFA) uses multifocal pupillographic objective perimetry (mfPOP) to measure the direct and consensual pupillary responses to spatially resolved stimuli. mfPOP assesses both sensitivity and response time at each of the visual field locations in both eyes simultaneously. 

The 30-degree and 15-degree tests are both approximately 7 mins, for both eyes, simultaneously.

objectiveFIELD (OFA) is 100% objective and utilizes a dichoptic presentation stimulus. It is easy on patients and technicians because there is no button to push and both eyes are tested at the same time.

Responses are measured objectively using a patented “Clustered Volley”, multifocal pupillographic objective perimetry method (mfPOP). OFA stimuli covers more than 99% of the 30-2 retinal area, while SAP Goldman III stimuli only samples approximately 0.5% of the 30-2 area with the assumption that the remaining 99.5% of the non-sampled central area is well represented by the small stimuli.

No. There are no disposable parts. Similar to many diagnostic devices, the forehead rest can be sanitized in between patients using alcohol wipes.

The human interface design is designed for a wide range of human morphology.

OFA stimuli are designed to be less susceptible to refractive errors and lens brunescence than SAP. Trial lenses are provided in 3 diopter steps for larger refractive errors.

Specifications

Fundamental Method Multifocal pupillographic objective perimetry (mfPOP)
Intended Clinical Purpose and Use Visual field examination to measure visual field defects
Visual System Stimulus Patented clustered volley, sparse, multifocal stimulus
Measurement Technology Video camera based pupil measurement
Visual Function Assessment Regression based multifocal analysis
Visual Field Defect Assessment Population sample normal database comparison
Test Options 30°, 24°, 15° tests
Trial Lenses +3D, -3D, +6D, -6D, +9D, -9D
Background Brightness 10 cd/m2
Regulatory FDA 510(k) Cleared K063310